AIGH Capital Management »

SPDR S&P Biotech shares owned by AIGH Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $93M 1.0M 92.71
2024-03-31 $95M 1.0M 94.89

More positions owned by AIGH Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Western Digital Call Option (WDC)
Silicon Motion Technology Sponsored Adr (SIMO)
Infinera (INFN)
Delcath Sys Com New (DCTH)
Scpharmaceuticals (SCPH)
Advanced Emissions (ARQ)
Myomo Com New (MYO)
Biodesix (BDSX)
Elutia Cl A Com (ELUT)
Tela Bio (TELA)
Cellectar Biosciences Com New (CLRB)
Eagle Pharmaceuticals (EGRX)
Electrovaya Com New (ELVA)
Intellicheck Com New (IDN)

View all positions for AIGH Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Bank of America Corporation
Citigroup
Citadel Advisors
Morgan Stanley
Millennium Management
Bnp Paribas Arbitrage, Snc
Susquehanna International
Healthcare Of Ontario Pension Plan Trust Fund
Twin Tree Management
Parallax Volatility Advisers
Logos Global Management
Balyasny Asset Management
Wells Fargo & Company

View all funds holding SPDR S&P Biotech